Rallybio Corp. (RLYB)
16.80
-0.03
(-0.18%)
USD |
NASDAQ |
Aug 24, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
Rallybio EPS Diluted (Quarterly) : 7.531 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.531 |
| March 31, 2026 | -1.455 |
| December 31, 2025 | -1.108 |
| September 30, 2025 | 2.844 |
| June 30, 2025 | -1.731 |
| March 31, 2025 | -0.2108 |
| December 31, 2024 | -1.978 |
| September 30, 2024 | -0.2571 |
| June 30, 2024 | -0.3679 |
| March 31, 2024 | -0.4667 |
| December 31, 2023 | -0.4981 |
| September 30, 2023 | -0.4533 |
| June 30, 2023 | -0.4616 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4303 |
| December 31, 2022 | -0.4562 |
| September 30, 2022 | -0.5969 |
| June 30, 2022 | -0.5748 |
| March 31, 2022 | -0.4782 |
| December 31, 2021 | -0.3864 |
| September 30, 2021 | -0.3173 |
| June 30, 2021 | -0.4188 |
| March 31, 2021 | -0.4132 |
| December 31, 2020 | -2.619 |
| September 30, 2020 | -0.306 |
| June 30, 2020 | -0.6474 |
| March 31, 2020 | -0.1208 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Q32 Bio, Inc. | -0.4398 |
| Beam Therapeutics, Inc. | -1.176 |
| C4 Therapeutics, Inc. | -0.1808 |
| Cullinan Therapeutics, Inc. | -0.8666 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 43.66M |
| Total Expenses (Quarterly) | -43.66M |
| Enterprise Value | -3.534M |
| Earnings Yield | 46.50% |
| Normalized Earnings Yield | 14.75 |